Safety and Immunogenicity of Personalized Genomic Vaccine to Treat Malignancies
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT02721043 |
|
Recruitment Status :
Recruiting
First Posted : March 28, 2016
Last Update Posted : February 15, 2018
|
Sponsor:
Nina Bhardwaj
Information provided by (Responsible Party):
Nina Bhardwaj, Icahn School of Medicine at Mount Sinai
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | July 2020 |
| Estimated Study Completion Date : | July 2020 |